Edesa Biotech, Inc.
EDSA
$1.96
-$0.075-3.69%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 13.90M | 1.56M | 1.04M | 2.04M | 2.80M |
Total Receivables | 382.40K | 350.60K | 270.90K | 551.10K | 1.11M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 108.20K | 157.80K | 367.40K | 454.70K | 330.30K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 14.39M | 2.07M | 1.68M | 3.05M | 4.24M |
|
|||||
Total Current Assets | 14.39M | 2.07M | 1.68M | 3.05M | 4.24M |
Net Property, Plant & Equipment | -- | -- | 18.40K | 36.30K | 62.30K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 2.03M | 2.05M | 2.08M | 2.10M | 2.13M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 38.70K | 38.70K | 41.20K | 40.70K | 41.10K |
Total Assets | 16.45M | 4.16M | 3.81M | 5.23M | 6.48M |
|
|||||
Total Accounts Payable | 914.70K | 1.90M | 1.81M | 2.32M | 2.09M |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | 19.90K | 38.80K | 58.10K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 914.70K | 1.90M | 1.83M | 2.36M | 2.15M |
|
|||||
Total Current Liabilities | 914.70K | 1.90M | 1.83M | 2.36M | 2.15M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 914.70K | 1.90M | 1.83M | 2.36M | 2.15M |
|
|||||
Common Stock & APIC | 68.50M | 61.74M | 60.81M | 60.72M | 60.51M |
Retained Earnings | -61.86M | -60.23M | -58.59M | -57.63M | -55.96M |
Treasury Stock & Other | -287.70K | -224.00K | -242.60K | -224.80K | -226.40K |
Total Common Equity | 6.35M | 1.28M | 1.98M | 2.87M | 4.32M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 9.19M | 981.20K | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 9.19M | 981.20K | -- | -- | -- |
|
|||||
Total Common Equity | 6.35M | 1.28M | 1.98M | 2.87M | 4.32M |
Total Preferred Equity | 9.19M | 981.20K | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 15.54M | 2.26M | 1.98M | 2.87M | 4.32M |
|